Nomura Holdings Inc. decreased its stake in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 78.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,818 shares of the company's stock after selling 80,921 shares during the period. Nomura Holdings Inc.'s holdings in Keurig Dr Pepper were worth $747,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vident Advisory LLC lifted its position in Keurig Dr Pepper by 85.1% in the first quarter. Vident Advisory LLC now owns 26,641 shares of the company's stock worth $912,000 after purchasing an additional 12,250 shares during the period. WPG Advisers LLC bought a new position in Keurig Dr Pepper in the first quarter worth $43,000. State of Wyoming lifted its position in Keurig Dr Pepper by 61.1% in the first quarter. State of Wyoming now owns 11,325 shares of the company's stock worth $388,000 after purchasing an additional 4,294 shares during the period. Itau Unibanco Holding S.A. bought a new position in Keurig Dr Pepper in the first quarter worth $3,824,000. Finally, Landscape Capital Management L.L.C. lifted its position in Keurig Dr Pepper by 155.1% in the first quarter. Landscape Capital Management L.L.C. now owns 106,034 shares of the company's stock worth $3,628,000 after purchasing an additional 64,469 shares during the period. 93.99% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on the company. HSBC reaffirmed a "hold" rating and issued a $30.00 target price (down from $42.00) on shares of Keurig Dr Pepper in a research report on Tuesday, August 26th. UBS Group reduced their target price on Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating for the company in a research report on Wednesday, August 27th. Barclays raised their target price on Keurig Dr Pepper from $37.00 to $39.00 and gave the stock an "overweight" rating in a research report on Monday, July 28th. Hsbc Global Res cut Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 26th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating on the stock in a report on Thursday, July 17th. Eleven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $38.38.
View Our Latest Analysis on KDP
Keurig Dr Pepper Price Performance
Shares of KDP traded down $0.60 during trading hours on Friday, hitting $28.65. The stock had a trading volume of 21,094,736 shares, compared to its average volume of 18,428,686. The company's fifty day moving average is $32.94 and its two-hundred day moving average is $33.49. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.64 and a quick ratio of 0.40. Keurig Dr Pepper, Inc has a 52 week low of $28.58 and a 52 week high of $38.28. The stock has a market capitalization of $38.92 billion, a price-to-earnings ratio of 25.58, a P/E/G ratio of 1.57 and a beta of 0.47.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its earnings results on Thursday, July 24th. The company reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The business had revenue of $4.16 billion for the quarter, compared to analyst estimates of $4.14 billion. During the same quarter in the prior year, the firm earned $0.45 EPS. The firm's quarterly revenue was up 6.1% compared to the same quarter last year. On average, analysts anticipate that Keurig Dr Pepper, Inc will post 1.92 EPS for the current year.
Insider Activity
In related news, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $33.66, for a total transaction of $403,920.00. Following the transaction, the insider owned 82,511 shares in the company, valued at $2,777,320.26. This represents a 12.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert James Gamgort sold 208,000 shares of the company's stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $32.90, for a total transaction of $6,843,200.00. Following the transaction, the director owned 2,292,169 shares in the company, valued at approximately $75,412,360.10. This trade represents a 8.32% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 459,601 shares of company stock worth $15,228,872. 0.40% of the stock is owned by corporate insiders.
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Stories

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.